Edges in Network
| Network | GSE18864_egf1520 - GSE18864 - SiGN-BN HC+Bootstrap |
| Network Description | Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
| Node | SGMS2 |
| Upstream (Parents) |
|---|
| (<<) ANTXR1 → SGMS2 |
| (<<) ARSJ → SGMS2 |
| (<<) AXL → SGMS2 |
| (<<) CSGALNACT2 → SGMS2 |
| (<<) CYP2U1 → SGMS2 |
| (<<) DNM3 → SGMS2 |
| (<<) EIF4E → SGMS2 |
| (<<) EMP1 → SGMS2 |
| (<<) GNG10 → SGMS2 |
| (<<) GPR153 → SGMS2 |
| (<<) GULP1 → SGMS2 |
| (<<) HS2ST1 → SGMS2 |
| (<<) MAP3K11 → SGMS2 |
| (<<) RHOQ → SGMS2 |
| (<<) RNF11 → SGMS2 |
| (<<) RXRB → SGMS2 |
| (<<) SH3GL1 → SGMS2 |
| (<<) STEAP1 → SGMS2 |
| (<<) TIMP2 → SGMS2 |
| (<<) TPM4 → SGMS2 |
| Downstream (Children) |
|---|
| SGMS2 → ADAM9 (>>) |
| SGMS2 → HIPK1 (>>) |
| SGMS2 → LGALS3 (>>) |
| SGMS2 → PRKAA1 (>>) |
| SGMS2 → PROCR (>>) |
| SGMS2 → S100P (>>) |
| SGMS2 → SCG5 (>>) |
| SGMS2 → SULT4A1 (>>) |
| SGMS2 → THBS1 (>>) |
| SGMS2 → UGDH (>>) |
| SGMS2 → VANGL1 (>>) |
